| Q35071511 | 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety |
| Q34531626 | 5-HT1A receptor knockout mouse as a genetic model of anxiety |
| Q31870055 | 5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response |
| Q28297569 | 50 years of hurdles and hope in anxiolytic drug discovery |
| Q37361257 | Alpha-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice |
| Q34117511 | Altered fear circuits in 5-HT(1A) receptor KO mice |
| Q35176167 | Animal models of anxiety disorders |
| Q43867264 | Anxiogenic activity of Myristica fragrans seeds |
| Q35534540 | Anxious and nonanxious mice show similar hippocampal sensory evoked oscillations under urethane anesthesia: difference in the effect of buspirone. |
| Q28593407 | Atp8a1 deficiency is associated with phosphatidylserine externalization in hippocampus and delayed hippocampus-dependent learning |
| Q43169237 | BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway |
| Q34571711 | Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity. |
| Q60959809 | Brain Vitamin E Deficiency During Development Is Associated With Increased Glutamate Levels and Anxiety in Adult Mice |
| Q35032878 | Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice |
| Q36411880 | Childhood trauma and personality disorder: toward a biological model |
| Q31514125 | Chronic cocaine differentially affects diazepam's anxiolytic and anticonvulsant actions. Relationship to GABA(A) receptor subunit expression |
| Q42436765 | Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action |
| Q48615603 | Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour |
| Q35598139 | Decreased GABAA receptor binding in the medullary serotonergic system in the sudden infant death syndrome |
| Q28307036 | Developmental psychopathology and neurobiology of aggression |
| Q43619730 | Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis |
| Q46585539 | Early postnatal stress alters the 5-HTergic modulation to emotional stress at postadolescent periods of rats |
| Q36777159 | Effect of 3α-anderostanediol and indomethacin on acquisition, consolidation and retrieval stage of spatial memory in adult male rats. |
| Q43813710 | Effects of cholecystokinin tetrapeptide (CCK(4)) and anxiolytic drugs on the electrically evoked [(3)H]5-hydroxytryptamine outflow from rat cortical slices |
| Q37361242 | Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior |
| Q40579168 | GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background |
| Q34448259 | GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice |
| Q35187929 | GABAergic dysfunction in mood disorders. |
| Q43483807 | Gender-specific abnormalities in the serotonin transporter system in panic disorder |
| Q35104041 | Genetic animal models of anxiety |
| Q30487278 | Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease |
| Q58554121 | HBK-17, a 5-HT Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling |
| Q35854228 | Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. |
| Q35834300 | Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter |
| Q41833242 | Inactivation of GIRK channels weakens the pre- and postsynaptic inhibitory activity in dorsal raphe neurons. |
| Q33947181 | Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice. |
| Q48487138 | Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. |
| Q34906869 | Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex |
| Q37268540 | Intrahippocampal Injection of 3α Diol (a Testosterone Metabolite ) and Indomethacin (3α-HSD Blocker), Impair Acquisition of Spatial Learning and Memory in Adult Male Rats |
| Q43880331 | Light-potentiation of acoustic startle response (ASR) and monoamine efflux related to fearfulness in Fyn-deficient mice |
| Q37039183 | Maternal profiling of corticotropin-releasing factor receptor 2 deficient mice in association with restraint stress |
| Q36026076 | Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways |
| Q34510367 | Molecular pathways of anxiety revealed by knockout mice |
| Q43728714 | Motor cortex excitability correlates with an anxiety-related personality trait |
| Q34574021 | Mouse anxiety: the power of knockout |
| Q30419666 | Neonatal testosterone partially organizes sex differences in stress-induced emotionality in mice |
| Q30498893 | Neurobiology of memory and anxiety: from genes to behavior |
| Q35195703 | New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. |
| Q33999587 | Panic disorder |
| Q92761255 | Panic disorders: The role of genetics and epigenetics |
| Q34116530 | Pharmacogenetics and the serotonin system: initial studies and future directions. |
| Q34980499 | Pharmacogenetics of anxiolytic drugs. |
| Q33919784 | Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats. |
| Q37600399 | RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer. |
| Q36235620 | Rapid response to fluoxetine in women with premenstrual dysphoric disorder |
| Q33927727 | Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injury. |
| Q44000320 | Reduced anxiety-- and depression-like behaviors in Emx1 homozygous mutant mice |
| Q34350194 | Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. |
| Q43937540 | Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult |
| Q30475973 | Serotonin1A receptor deletion does not interact with maternal separation-induced increases in startle reactivity and prepulse inhibition deficits |
| Q35163769 | Somatostatin, neuronal vulnerability and behavioral emotionality |
| Q46598643 | State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice. |
| Q40604724 | Stress-induced hyperthermia in the 5-HT(1A) receptor knockout mouse is normal |
| Q33720433 | Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus |
| Q37159970 | TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes |
| Q60501981 | The Behavioral Genetics of Serotonin: Relevance to Anxiety and Depression |
| Q30417098 | The Role of Genetic Sex in Affect Regulation and Expression of GABA-Related Genes Across Species |
| Q35071483 | The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines |
| Q35584090 | The developmental role of serotonin: news from mouse molecular genetics |
| Q35202929 | The neurobiology and control of anxious states |
| Q34756886 | The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective |
| Q34105817 | The neurobiology of stress: from serendipity to clinical relevance |
| Q35094630 | The role of hormones and hormonal treatments in premenstrual syndrome. |
| Q36917104 | The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders |
| Q37295518 | The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice |
| Q35682947 | The serotonergic system and anxiety |
| Q44978629 | Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors. |